Protein turnover by the proteasome in aging and disease 1,2 1This article is part of a series of reviews on “Oxidatively Modified Proteins in Aging and Disease.” The full list of papers may be found on the homepage of the journal.Davies and Shringarpure are studying the mechanism by which the proteasome recognizes and degrades oxidatively damaged proteins, and how protein oxidation and proteolysis are affected by aging and disease. 2Guest Editor: Earl Stadtman
- 20 May 2002
- journal article
- review article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 32 (11), 1084-1089
- https://doi.org/10.1016/s0891-5849(02)00824-9
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I— effects of proliferative senescenceThe FASEB Journal, 2000
- Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblastsThe FASEB Journal, 2000
- Hybrid ProteasomesJournal of Biological Chemistry, 2000
- Aging of C. elegans: Mosaics and MechanismsCell, 1998
- Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophoresFree Radical Biology & Medicine, 1996
- Inefficient Degradation of Oxidized Regions of Protein MoleculesFree Radical Research Communications, 1993
- Proteases and proteolysis in the lysosomeCellular and Molecular Life Sciences, 1992
- Macroxyproteinase (M.O.P.): A 670 kDa Proteinase complex that degrades oxidatively denatured proteins in red blood cellsFree Radical Biology & Medicine, 1989
- Cation‐Sensitive Neutral Endopeptidase: Isolation and Specificity of the Bovine Pituitary EnzymeJournal of Neurochemistry, 1980
- Aging: A Theory Based on Free Radical and Radiation ChemistryJournal of Gerontology, 1956